Australian Sepsis Network

Here you'll find a suite of free sepsis resources, including free CPD/CME-accredited lectures from some of the leading sepsis experts in the world.

The Australian Sepsis Network is a collaborative of individuals and organisations working to improve outcomes for patients with sepsis and to provide information and support to the families and friends of people with sepsis. To find out more, visit www.australiansepsisnetwork.net.au

Our sponsors
Partner Menu

Why paediatric sepsis is different

Learn about the differences in paediatric sepsis epidemiology, recognition and management
1 Credit(s)

1 CPD point, 1 AMA PRA Category 1 Credit, 1 CEU
Providers: CPDUK, EB Medicine, CBRN

Luregn Schlapbach Read bio

×
Luregn Schlapbach

Luregn Schlapbach, MD

Head of the Pediatric and Neonatal Intensive Care Unit at the University Children`s Hospital Zurich, Switzerland

Professor Luregn Schlapbach is Head of the 41-bed multidisciplinary Pediatric and Neonatal Intensive Care Unit at the University Children`s Hospital Zurich, Switzerland. He has published over 130 papers in the field and has received over $10M grants for his research.

He worked for a decade as a pediatric intensivist in Australia including Staff Specialist in the ICU at Queensland Children`s Hospital in Brisbane, Australia, and he maintains an active research program on Sepsis, Infection, and Inflammation in Critically Ill Children at the Child Health Research Centre, University of Queensland. He is Past Chair of the Australian and New Zealand Intensive Care Society Paediatric Study Group.

Prof. Schlapbach`s research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis and severe infections in children. He has been leading observational, genomic, and interventional studies in the field, is involved in international consortia on life-threatening childhood infections, and serves in the steering board of several large pediatric trials.

Prof. Schlapbach is an internationally recognized expert in sepsis and other life-threatening infectious and inflammatory conditions, as evidenced by his work as group head on the Pediatric Surviving Sepsis Campaign, and Co-Chairmanship of the international Paediatric Sepsis Definition Taskforce. In recognition of his contribution to quality improvement initiatives for critically ill children, Prof. Schlapbach recently has been elected to the Global Sepsis Alliance Executive.

 

CME Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation. 

Wednesday, May 19, 2021

9:00 AM (GMT/UTC)

Find the right time in your country

Access Lecture

Webinar time: 9am GMT; 10am UK; 7pm AEST 

Talk Summary:
Coming Soon

Learning Objectives:
By the end of this lecture the attendee will be able to:

  1. Understand the epidemiology of paediatric sepsis
  2. Learn about the differences in paediatric sepsis recognition
  3. Discover some key considerations for paediatric sepsis management
  4. Increase your awareness of paediatric differences identified through a real-life program intervention

 If you can't make the live recording, don't worry, the recording will be available shortly after

 

Additional CME Info

Release Date: February 1, 2020, Termination Date: January 31, 2023

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: EB Medicine designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per lecture. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Commercial Support: This activity received no commercial support.

Earning Credit: In order to earn CME credit, the participant must take the pre-test, listen to the lecture, take the CME post-test, and complete the post-test evaluation.